Gans Myra D

Avg. Two Year Performance

No purchase track record
55% Avg. Sale Return
24% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)(3%)6%34%55%
Sale Success Rate3 of 53 of 54 of 55 of 54 of 5
Drugs » Drug Related Products

Executive Vice President:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--